QRG Capital Management Inc. decreased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 6.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 40,774 shares of the semiconductor company’s stock after selling 2,965 shares during the period. QRG Capital Management Inc.’s holdings in Synopsys were worth $19,790,000 as of its most recent SEC filing.
Other large investors have also recently modified their holdings of the company. State Street Corp boosted its stake in Synopsys by 1.7% during the third quarter. State Street Corp now owns 6,948,473 shares of the semiconductor company’s stock worth $3,518,637,000 after acquiring an additional 119,057 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Synopsys by 1.9% during the third quarter. Geode Capital Management LLC now owns 3,281,867 shares of the semiconductor company’s stock valued at $1,656,005,000 after purchasing an additional 61,799 shares during the last quarter. Edgewood Management LLC raised its holdings in shares of Synopsys by 18.9% during the third quarter. Edgewood Management LLC now owns 3,069,848 shares of the semiconductor company’s stock valued at $1,554,540,000 after purchasing an additional 487,025 shares during the last quarter. Van ECK Associates Corp raised its holdings in shares of Synopsys by 26.5% during the third quarter. Van ECK Associates Corp now owns 1,605,001 shares of the semiconductor company’s stock valued at $791,923,000 after purchasing an additional 335,993 shares during the last quarter. Finally, Parnassus Investments LLC purchased a new stake in Synopsys during the third quarter valued at approximately $633,469,000. Institutional investors own 85.47% of the company’s stock.
Insider Activity at Synopsys
In other news, CRO Richard S. Mahoney sold 20,838 shares of the stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the sale, the executive now owns 1,460 shares of the company’s stock, valued at approximately $738,774.60. This represents a 93.45 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.62% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on Synopsys
Synopsys Stock Up 2.7 %
Synopsys stock opened at $470.46 on Thursday. The company has a market cap of $72.72 billion, a price-to-earnings ratio of 32.40, a PEG ratio of 3.23 and a beta of 1.12. The firm’s fifty day moving average is $507.61 and its 200 day moving average is $516.56. Synopsys, Inc. has a 52-week low of $457.00 and a 52-week high of $624.80.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- Find and Profitably Trade Stocks at 52-Week Lows
- Domino’s Pizza Delivers a Buying Opportunity
- How to Buy Cheap Stocks Step by Step
- These Consumer Staples Shine Amid Market Turmoil
- How to Use Stock Screeners to Find Stocks
- Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.